Short Interest in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Increases By 130.0%

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPWGet Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,930 shares, an increase of 130.0% from the August 15th total of 839 shares. Based on an average daily volume of 4,166 shares, the days-to-cover ratio is presently 0.5 days.

60 Degrees Pharmaceuticals Stock Performance

Shares of SXTPW stock opened at $0.03 on Monday. 60 Degrees Pharmaceuticals has a fifty-two week low of $0.02 and a fifty-two week high of $0.15. The stock has a 50 day moving average price of $0.03 and a two-hundred day moving average price of $0.04.

About 60 Degrees Pharmaceuticals

(Get Free Report)

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.

See Also

Receive News & Ratings for 60 Degrees Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.